|
|
||||||||


*
Department of Dermatology, University of Tokyo, Tokyo, Japan; and
Biomedical Research Center, Osaka University Medical School, Osaka, Japan
We investigated the capacity of mouse Langerhans cells (LC) to
produce IL-12, a central cytokine in a Th1 type of immune responses. We
prepared purified LC (>95%) from BALB/c mouse skin by the panning
method using anti-I-Ad mAb. An ELISA showed that
purified LC spontaneously produced IL-12 p40, and that its production
was up-regulated following simultaneous stimulation with anti-CD40
mAb and IFN-
. Surprisingly, GM-CSF strikingly inhibited IL-12 p40
production by anti-CD40/IFN-
-stimulated LC (% inhibition =
97.0 ± 0.9% at 1 ng/ml GM-CSF). Supernatants of 48-h cultured
keratinocytes (KC) also caused the inhibition of LC IL-12 p40
secretion, and this effect was neutralized by anti-GM-CSF mAb.
IL-1
(1 ng/ml)-stimulated KC produced much more GM-CSF than
unstimulated KC (60.9 ± 0.2 pg/ml vs 20.9 ± 1.7 pg/ml), and
IL-1
-stimulated KC supernatants strongly inhibited IL-12 p40
production by anti-CD40/IFN-
-stimulated LC (% inhibition =
89.4 ± 1.4%). A bioassay using an IL-12-dependent T cell line
demonstrated the correlation of the level of IL-12 p40 with the
bioactivity of IL-12. These results provide important implications for
the pathogenesis of atopic dermatitis, which involves the participation
of LC and KC with the capacity to produce IL-12 and GM-CSF,
respectively.
This article has been cited by other articles:
![]() |
M. Peiser, R. Wanner, and G. Kolde Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking J. Leukoc. Biol., September 1, 2004; 76(3): 616 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Lipscomb and B. J. Masten Dendritic Cells: Immune Regulators in Health and Disease Physiol Rev, January 1, 2002; 82(1): 97 - 130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |